Arcutis Biotherapeutics Inc (ARQT)
Stock-Based Compensation
$43.55M
TTM · Period ending: · USD
ARQT Stock-Based Compensation
Latest reported$43.55Mperiod ending
Latest reported$43.55Mperiod ending
ARQT TTM Stock-Based Comp ($151.00K → $43.55M)
TTM stock-based compensation
High-resolution chart · PNG
ARQT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 43,549,000 | |
| 41,276,000 | |
| 40,364,000 | |
| 39,697,000 | |
| 39,444,000 | |
| 41,478,000 | |
| 41,730,000 | |
| 41,094,000 | |
| 41,309,000 | |
| 39,364,000 | |
| 38,813,000 | |
| 39,320,000 | |
| 38,110,000 | |
| 35,628,000 | |
| 32,682,000 | |
| 29,104,000 | |
| 25,678,000 | |
| 21,922,000 | |
| 23,892,000 | |
| 20,849,000 | |
| 15,486,000 | |
| 13,195,000 | |
| 5,682,000 | |
| 3,494,000 | |
| 3,648,000 | |
| 1,738,000 | |
| 824,000 | |
| 425,000 | |
| 324,000 | |
| 206,000 | |
| 151,000 |